cdmo.directory
← Compare landing

Pluri vs RoslinCT

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/pluri-biotech/roslinct

CategoryPluriRoslinCT
Listed sitecdmocdmo
SummaryFull-service CDMO specializing in cell therapy manufacturing with GMP facilities, proprietary packed-bed expansion technology, and regulatory approvals from FDA, EMA, PMDA, and other key agencies for clinical-stage production.RoslinCT is a cell and gene therapy CDMO offering cGMP iPSC banking, process and analytical development, and clinical and commercial manufacturing for autologous and allogeneic programs.
Services
  • Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Cell-Line Development
  • Process Development
  • CMC Analytical Development
  • Formulation Development
  • Technology Transfer
  • Cold-Chain Storage & Logistics
  • Autologous Cell Therapy Manufacturing
  • CMC Regulatory Submission Support
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Cell-Line Development
  • CMC Analytical Development
  • Process Development
  • Technology Transfer
  • Quality Control Testing
Modalities
  • Cell Therapy
  • Cell Therapy
  • Gene Therapy
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters, Haifa, Haifa, Israel
  • USA Office, USA
  • Boston facility, Boston, Massachusetts, United States
Certifications
  • FDA · Identifier: U.S. Food and Drug Administration
  • EMA · Identifier: European Medicines Agency
  • PMDA · Identifier: Japan's Pharmaceuticals and Medical Devices Agency
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.